{"lastClose": 3.4700000286102295, "len": 389, "date": "2022-12-30", "alpha_1": -0.19419899427169207, "beta_1": 1.6672874656825485, "drawup_1": 1.2472826923210234, "natr_1": 20.23359304293473, "sup_1": -0.09164258146626518, "res_1": 0.272622481818293, "bullPattern_1": ["CLOSINGMARUBOZU"], "bearPattern_1": [], "rsi_1": 31.655844294073866, "adx_1": 56.505674856760095, "drawdown_1": -0.6638452457665858, "stratHoldSharpe_1": -0.5670766908084368, "stratHoldAlpha_1": 250.58353194403688, "stratHoldDrawdown_1": -0.6013143731003551, "alpha_3mo": -0.9826809954591295, "beta_3mo": 1.7166502477148806, "drawup_3mo": 0.24820146198617254, "natr_3mo": 20.23359304293473, "sup_3mo": -0.22190203286763832, "res_3mo": 0.040345805419064205, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 48.97360433163988, "adx_3mo": 38.3830542668208, "drawdown_3mo": -0.6563658938250474, "stratHoldSharpe_3mo": -4.112502314667065, "stratHoldAlpha_3mo": 248.17607033512914, "stratHoldDrawdown_3mo": -0.5907293044425426, "Sector": "Health Care", "Industry": "Biotechnology: Pharmaceutical Preparations", "Market Cap": 865159926, "Name": "Lyell Immunopharma Inc.", "IPO Year": 2021.0, "Country": "United States", "alpha%_1": 0.45203373348785075, "beta%_1": 0.9067112900169912, "drawup%_1": 0.992593903412203, "natr%_1": 0.9999999994199318, "drawdown%_1": 0.10503509413255924, "stratHoldSharpe%_1": 0.3249047060789529, "stratHoldAlpha%_1": 0.15152306920498382, "stratHoldDrawdown%_1": 0.10745874383267229, "alpha%_3mo": 0.06415932406961507, "beta%_3mo": 0.9216667892460388, "drawup%_3mo": 0.4892139122590539, "natr%_3mo": 0.9999999990006244, "drawdown%_3mo": 2.5115188282347244e-06, "stratHoldSharpe%_3mo": 0.0022737017341255775, "stratHoldAlpha%_3mo": 4.043331628495592e-08, "stratHoldDrawdown%_3mo": 3.037764495667376e-06}